http://www.xconomy.com/san-diego/2008/11/10/optimer-shares-skyrocket-as-drug-halts-deadly-bacterial-infection-in-trial/ Business + Technology in the Exponential Economy Mon, 23 Nov 2009 05:27:07 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/san-diego/2008/11/10/optimer-shares-skyrocket-as-drug-halts-deadly-bacterial-infection-in-trial/comment-page-1/#comment-37832 New Book Explains Why Correct Answers In Medical Research Are So Hard To Achieve | OncoBlog.com Tue, 11 Nov 2008 03:48:19 +0000 http://www.xconomy.com/?p=6132#comment-37832 [...] Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial [...] [...] Optimer Shares Skyrocket, as Drug Halts Deadly Bacterial Infection in Trial [...]

]]> http://www.xconomy.com/san-diego/2008/11/10/optimer-shares-skyrocket-as-drug-halts-deadly-bacterial-infection-in-trial/comment-page-1/#comment-37813 Minding Your Business » Blog Archive » Afternoon Local Business Update Tue, 11 Nov 2008 01:22:38 +0000 http://www.xconomy.com/?p=6132#comment-37813 [...] Optimer shares double in after-hours trading on antibiotic news * Cardium Therapeutics has completed a $6 million debt financing * $100 billion isn’t enough [...] [...] Optimer shares double in after-hours trading on antibiotic news * Cardium Therapeutics has completed a $6 million debt financing * $100 billion isn’t enough [...]

]]>